Figure 2.
Hyperacetylation suppresses growth of MDA-MB-231 cells implanted in female nude mice. (A–D) Effect of oral administration of 20 mg/(kg·day) ASA plus subcutaneous injection of 0.5 mg/kg TSA three times weekly on total body weight (A), body weight in the absence of tumors (B), tumor volume, (C) and wet-tumor weight (D). Data reflect the mean (n = 6–7 mice/group, with tumor cells orthotopically injected into the mammary fat pad of each mouse). *P < 0.05 versus control mice according to one-way ANOVA, followed by Bonferroni’s test. (E) Representative micro-CT of xenografts treated with 20 mg/(kg·day) + 0.5 mg/kg TSA, TSA alone or SA.